Anti-Anxiety & Anti-Depressants

Anti-Anxiety & Antidepressant Compounds in Canada | Peptides, Glutamate Modulators & Novel Antidepressants

Canada Steroid Depot's anti anxiety and anti depressant category covers the most actively researched non traditional anxiolytic and antidepressant compound classes. From peptide anxiolytics with dual cognitive enhancing profiles, to rapid acting glutamate modulators, to novel antidepressants with melatonergic and serotonergic mechanisms, to neurotrophin enhancing compounds that address the neuroplasticity deficits underlying treatment resistant depression. Each compound class targets distinct neurobiological mechanisms beyond the monoamine pathways of traditional SSRIs and benzodiazepines.

Peptide anxiolytics | Selank and Semax

Selank and Semax are the two most extensively researched peptide compounds for anxiety and mood disorders. Selank is a synthetic analogue of the endogenous immunomodulatory peptide tuftsin, developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It demonstrates anxiolytic effects comparable to benzodiazepines in animal models without sedation, tolerance development, or withdrawal while simultaneously enhancing memory, focus, and immune function. Semax is a synthetic ACTH analogue that upregulates BDNF expression, enhances dopaminergic and serotonergic neurotransmission, and exerts neuroprotective effects. Both compounds are administered intranasally for optimal bioavailability and are available in CSD's nasal spray format.

BPC-157 for depression and anxiety

Body Protection Compound 157 (BPC-157) is increasingly researched for its effects on the central nervous system beyond its well known tissue repair properties. BPC-157 modulates the dopaminergic and serotonergic systems, upregulates GABA receptors, and demonstrates anxiolytic and antidepressant effects in multiple animal models of depression and anxiety. Research suggests BPC-157 may counteract dopamine system dysregulation with particular relevance to anhedonia, motivation deficits, and stress induced mood disorders. Its gut brain axis effects via vagus nerve modulation are also an active area of research.

Novel antidepressants | Tianeptine and Agomelatine

Tianeptine is a tricyclic antidepressant with a unique mechanism acting as a mu and delta opioid receptor agonist and glutamate modulator rather than a monoamine reuptake inhibitor. It produces antidepressant effects with anxiolytic properties and cognitive enhancement rather than the cognitive blunting associated with SSRIs. Agomelatine is a melatonergic (MT1/MT2) agonist and 5-HT2C antagonist antidepressant with a circadian rhythm resynchronizing mechanism. Producing antidepressant effects with improvements in sleep architecture, energy, and daytime functioning without the sexual dysfunction or discontinuation syndrome associated with SSRI/SNRI compounds.